The estimated Net Worth of Harold Ruf is at least $431 mil dollars as of 16 June 2022. Harold Ruf owns over 1,235 units of OrthoPediatrics corp stock worth over $431,309 and over the last 7 years Harold sold KIDS stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Harold Ruf KIDS stock SEC Form 4 insiders trading
Harold has made over 3 trades of the OrthoPediatrics corp stock since 2017, according to the Form 4 filled with the SEC. Most recently Harold bought 1,235 units of KIDS stock worth $48,721 on 16 June 2022.
The largest trade Harold's ever made was buying 11,500 units of OrthoPediatrics corp stock on 16 October 2017 worth over $149,500. On average, Harold trades about 1,115 units every 122 days since 2017. As of 16 June 2022 Harold still owns at least 13,824 units of OrthoPediatrics corp stock.
You can see the complete history of Harold Ruf stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Harold Ruf's mailing address?
Harold's mailing address filed with the SEC is 2850 Frontier Dr, Warsaw, IN 46582, USA.
Insiders trading at OrthoPediatrics corp
Over the last 17 years, insiders at OrthoPediatrics corp have traded over $17,595,944 worth of OrthoPediatrics corp stock and bought 44,994 units worth $1,275,983 . The most active insiders traders include David R Pelizzon, John V. Schaefer, eMark C Throdahl. On average, OrthoPediatrics corp executives and independent directors trade stock every 24 days with the average trade being worth of $158,746. The most recent stock trade was executed by Daniel J Gerritzen on 21 August 2024, trading 10,000 units of KIDS stock currently worth $293,000.
What does OrthoPediatrics corp do?
orthopediatrics is the worldwide leader in pediatric orthopedics. we are the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. every day, we focus purely on advancing the field of pediatric orthopedics through the innovative development of state-of-the-art technologies, commitment to quality products, and industry-leading support and clinical education with our experienced team of experts. our offering is continuing to expand as we strive to develop all of the necessary implants and instruments that a pediatric orthopedic surgeon needs to treat his/her patients, including: long bone deformity correction & trauma, spine, and sports medicine. as we continue to grow, we are looking for talented professionals to join our cause! visit our website to learn more about current openings, or submit a resume to careers@orthopediatrics.com!
What does OrthoPediatrics corp's logo look like?
Complete history of Harold Ruf stock trades at OrthoPediatrics corp
OrthoPediatrics corp executives and stock owners
OrthoPediatrics corp executives and other stock owners filed with the SEC include:
-
Mark Throdahl,
Chief Executive Officer, Director -
Fred Hite,
Chief Financial Officer, Chief Operating Officer, Director -
Gregory Odle,
Executive Vice President -
David Bailey,
President -
Daniel Gerritzen,
Vice President of Legal and Human Resources, General Counsel, Secretary -
Mark C. Throdahl,
Exec. Chairman -
Fred L. Hite,
CFO, Principal Financial & Accounting Officer, COO and Director -
David R. Bailey,
Pres, CEO & Director -
Gregory A. Odle,
Exec. VP of Commercialization -
Daniel J. Gerritzen,
Gen. Counsel & Sec. -
Terry Schlotterback,
Independent Chairman of the Board -
Marie Infante,
Independent Director -
Bryan Hughes,
Independent Director -
Kevin Unger,
Independent Director -
Samuel Riccitelli,
Independent Director -
Stephen Burns,
Independent Director -
Bernie Berry,
Independent Director -
Harald Ruf,
Director -
David Pelizzon,
Director -
Tram Bui,
IR Contact Officer -
Paul J. Mraz,
Sr. VP & GM of Scoliosis -
Mark Karshner,
Sr. VP of International Sales -
Joe Hauser,
Sr. VP & GM of Trauma & Deformity Correction -
Dr. Peter F. Armstrong M.D.,
Chief Medical Officer & Chair of Surgeon Advisory Board -
Joel Batts,
Sr. VP of Science & Technology -
Jennifer N. Pritzker,
10% owner -
Frederick Hurley,
Senior VP Merchandising -
Craig Kimbrough Currie,
Senior VP My Twinn & BabyUnive -
Barry Hollingsworth,
Chief Financial Officer -
John V. Schaefer,
Director -
Edward John Ulbrich,
Director -
Michael J. Wagner,
Chief Executive Officer -
Christopher Cummings,
Senior VP & CIO -
Pamela Nadine Abrams,
Director -
Joseph Frank Rosales,
Director -
Direct Capital, L.L.C.D. E....,
-
John C Textor,
Director -
E. Shaw Laminar Acquisition...,
-
Harold Ruf,
Director -
George Sinclair Mitchell Dyer,
Director -
Joseph W Hauser,
Pres. Trauma & Def. Correction -
Capital Llc Squadron Capita...,
-
Jimmy Duane Mc Donald,
Director